PrimaryBid was pleased to support Oxford BioMedica plc ("the Company") during its latest capital raise.

As part of the Placing, retail and other investors have subscribed for 117,284 new ordinary shares in the Company (the "Retail Shares") at the Placing Price pursuant to the offer made by the Company via the PrimaryBid platform (the "Retail Offer"), with approximately 74 per cent of these being subscribed by existing shareholders of the Company. The Retail Offer raised gross proceeds of approximately £1.0 million for the Company.

Read the RNS here

‍